Company Profile
Updated: 19-DEC-08Janssen-kyowa Company Ltd.
International Private company
3-1-5 Higashi-gotanda Shinagawa-ku, Tokyo, Tokyo, 141, Japan
()334452222, 334452227 fax,
Primary SIC: Industrial Inorganic Chemicals, Not Elsewhere Classified, Primary NAICS: Inorganic Dye and Pigment Manufacturing
Description: Manufacturing: Manufacture of chemicals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets Adds Report: Eisai: Pipeline, Products, Performance and Potential.(Company overview)
Health & Beauty Close-Up; 12/9/2009; 1020 words; ...future. A section on company strategy covers...comprehensive review of the company's product portfolio...the larger pharma companies from Europe and...Tanabe Pharma and Kyowa Hakko Kirin...2006), and the company continues to strive...marketing with Janssen ...
Foreign Subsidiaries and Operations Generated 57.5 Per Cent of Eisai's Sales in Fiscal 2009 (Compared to 52.6 Per Cent in Fiscal 2006).
M2 Presswire; 12/2/2009; 1242 words; ...future. A section on company strategy covers...comprehensive review of the company's product portfolio...the larger pharma companies from Europe and...Tanabe Pharma and Kyowa Hakko Kirin...2006), and the company continues to strive...marketing with Janssen ...
Research and Markets: Foreign Subsidiaries and Operations Generated 57.5 Per Cent of Eisai's Sales in Fiscal 2009 (Compared to 52.6 Per Cent in Fiscal 2006).
Business Wire; 12/2/2009; 1196 words; ...future. A section on company strategy covers...comprehensive review of the company's product portfolio...the larger pharma companies from Europe and...Tanabe Pharma and Kyowa Hakko Kirin...2006), and the company continues to strive...marketing with Janssen ...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1553 words; ...Basilea Pharmaceutica Ltd., of Basel, Switzerland...agency granted partner Janssen-Cilag AG, a London...Biotech Holdings Ltd., of Vancouver...undisclosed private company based in Colombia...Pharmaceutical Co. Ltd., of Osaka, Japan...the Japanese firm Kyowa Hakko Kogyo Co...December ...
NPS Pharmaceuticals Secures $40 Million Committed Equity Financing Facility.
Biotech Week; 8/19/2009; 930 words; ...Azimuth Opportunity, Ltd. over an 18-month...the facility, the company will issue shares...endocrine disorders. The company is currently conducting...GlaxoSmithKline, Kyowa Kirin, Nycomed, and Ortho-McNeil-Janssen Pharmaceuticals...Pharmaceutical Company, NPS Pharmaceuticals...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
Related Company Profiles
- Vinilos Y Mangueras S.A. de C.V.
- Visaplast S.A. de C.V.
- Industrial Development Corporation of Zimbabwe Ltd.